2. TOP 10 Number of people with diabetes (20-79 years), 2010 and 2030

3. IDF Regions and global projections for the number of people with diabetes (20-79 years), 2010-2030

4. FIGURE 1.1 The major diabetes complications

5. FIGURE 1.2 Insulin production and action

6. AT A GLANCE World

7. TOP 10 Prevalence (%) of diabetes(20-79 years), 2010 and 2030

8. FIGURE 2.1 Prevalence (%) estimates of diabetes (20-79 years) by region, 2010 and 2030

9. FIGURE 2.2 Number of people with diabetes by age group, 2010 and 2030

10. MAP 2.1 Prevalence (%) estimates of diabetes (20-79 years), 2010

11. MAP 2.2 Prevalence (%) estimates of diabetes (20-79 years), 2030

12. FIGURE 2.3 Number of people with impaired glucose tolerance by age group, 2010 and 2030

13. TOP 10 Prevalence (%) of impaired glucose tolerance (20-79 years), 2010 and 2030

14. MAP 2.3 Prevalence (%) estimates of impaired glucose tolerance (20-79 years), 2010

15. FIGURE 2.4 Estimated number of prevalent cases of type 1 diabetes in children, 0-14 years, by region, 2010

16. MAP 2.4 New cases of type 1 diabetes in children, 0-14 years (cases per 100,000 aged 0-14 years per year), 2010

17. FIGURE 2.5 Effect of depression on all-cause mortality in people with diabetes

18. FIGURE 2.6 Summary of prevalence (%) ranges of diabetes complications (all diabetes) found in different studies

19. FIGURE 2.7 Deaths attributable to diabetes as percentage of all deaths (20-79 years) by region, 2010

20. MAP 2.5 Number of deaths attributable to diabetes (20-79 years), 2010

21. MAP 2.6 Mean health expenditure per person with diabetes (USD), R=2, 2010

22. TABLE 3.1 Regional estimates for diabetes (20-79 years), 2010 and 2030

23. AT A GLANCE African Region

24. MAP 3.1 Prevalence (%) estimates of diabetes (20-79 years), 2010 African Region

25. FIGURE 3.1 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, African Region

26. AT A GLANCE European Region

27. MAP 3.2 Prevalence (%) estimates of diabetes (20-79 years), 2010 European Region

28. FIGURE 3.2 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, European Region

29. AT A GLANCE Middle East and North African Region

30. MAP 3.3 Prevalence (%) estimates of diabetes (20-79 years), 2010 Middle East and North African Region

31. FIGURE 3.3 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, Middle East and North African Region

32. AT A GLANCE North America and Caribbean Region

33. MAP 3.4 Prevalence (%) estimates of diabetes (20-79 years), 2010 North America and Caribbean Region

34. FIGURE 3.4 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, North America and Caribbean Region

35. AT A GLANCE South and Central American Region

36. MAP 3.5 Prevalence (%) estimates of diabetes (20-79 years), 2010 South and Central American Region

37. FIGURE 3.5 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, South and Central American Region

38. AT A GLANCE South-East Asian Region

39. MAP 3.6 Prevalence (%) estimates of diabetes (20-79 years), 2010 South-East Asian Region

40. FIGURE 3.6 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, South-East Asian Region

41. AT A GLANCE Western Pacific Region

42. MAP 3.7 Prevalence (%) estimates of diabetes (20-79 years), 2010 Western Pacific Region

43. FIGURE 3.7 Percentage of all-cause mortality attributable to diabetes by age and sex, 2010, Western Pacific Region

44. FIGURE 4.1 Perceived barriers to diabetes education

45. MAP 5.1 National Diabetes Programmes (NDP)

46. FIGURE 5.1 Affordability and availability of insulin

47. TABLE 5.1 Cost of diabetes care

48. FIGURE 6.1 Likelihood and severity of risks to global development